Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Israeli Weekender.
Press releases published on May 7, 2025

300 Pastors, Rabbis, and Faith Leaders Forge Alliance for Israel Advocacy in the Nation’s Capital
Influential rabbis and pastors met in Washington, D.C. to urge Congress for stronger support for Israel. WASHINGTON, DC, DC, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- Influential rabbis and pastors met in Washington, D.C. to urge Congress for …

Live From Gaza: Doctors Fighting to Spare Thousands of Children From Starvation to Issue Plea in International ZOOM Call
Providers struggling against catastrophic conditions in northern Gaza while witnessing a child dying every 40 minutes are begging: Let the children eat! WASHINGTON (DC), DC, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- In Gaza, the World Food …

ImmuneWalk Therapeutics Announces $7 Million Seed Financing and Upcoming Presentations of Positive Clinical Results at Upcoming Medical and Industry Conferences
Completed seed financing round of $7 million from an institutional investor and ImmuneWalk’s management team Includes oral presentation of positive safety, pharmacokinetic, and pharmacodynamic data from immunology and inflammation (I…

Introducing the Wix Model Context Protocol (MCP) Server for Seamless AI-Driven Web App Development
With Wix MCP Server, users can leverage natural language prompts to seamlessly connect Wix’s comprehensive business functionality with their preferred compatible AI-powered tools, enabling them to build custom experiences on top of Wix or manage their Wix- …

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients
RA'ANANA, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that the INSPIRA™ ART100 has been …

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved
For an accessible version of this Press Release, please visit www.tevapharm.com On track for 30% operating profit margin by 2027 in line with our Pivot to Growth Strategy; Q1 2025 shows ninth consecutive quarter of revenue growth, excluding revenues …